Deng Wei (Wei Deng)

Publication Activity (10 Years)

Years Active: 2019-2023
Publications (10 Years): 10

Top Topics

Cardiac Resynchronization Therapy

Cardiovascular Risk Factors

Top Venues

Oxidative medicine and cellular longevity

Signal transduction and targeted therapy

BioMed research international

Mediators of inflammation

This page only lists publications with an associated author ORCID identifier.

Publications

Saiyang Xie, Si-Chi Xu, Deng Wei, Qizhu Tang
Metabolic landscape in cardiac aging: insights into molecular biology and therapeutic implications. Signal transduction and targeted therapy 8 (1) (2023)
Wenxi Fang, Saiyang Xie, Deng Wei
Epicardial Adipose Tissue: a Potential Therapeutic Target for Cardiovascular Diseases. Journal of cardiovascular translational research (2023)
Saiyang Xie, Si-Chi Xu, Deng Wei, Qizhu Tang
Metabolic landscape in cardiac aging: insights into molecular biology and therapeutic implications. Signal transduction and targeted therapy 8 (1) (2023)
Saiyang Xie, Si-Chi Xu, Deng Wei, Qizhu Tang
Metabolic landscape in cardiac aging: insights into molecular biology and therapeutic implications. Signal transduction and targeted therapy 8 (1) (2023)
Hai-Han Liao, Jin-Xiu Zhu, Hong Feng, Jian Ni, Nan Zhang, Si Chen, Huang-Jun Liu, Zheng Yang, Deng Wei, Qi-Zhu Tang
Corrigendum to "Myricetin Possesses Potential Protective Effects on Diabetic Cardiomyopathy through Inhibiting IκBα/NFκB and Enhancing Nrf2/HO-1". Oxidative medicine and cellular longevity 2021 (2021)
Xie Saiyang, Wu Qingqing, Xu Man, Liu Chen, Zhang Min, Xing Yun, Shi Wenke, Wu Haiming, Zeng Xiaofeng, Chen Si, Guo Haipeng, Deng Wei, Qi-Zhu Tang
Activation of Toll-like receptor 7 provides cardioprotection in septic cardiomyopathy-induced systolic dysfunction. Clinical and translational medicine 11 (1) (2021)
Ling-Li Li, Li Wei, Ning Zhang, Wen-Ying Wei, Can Hu, Deng Wei, Qi-Zhu Tang
Levosimendan Protects against Doxorubicin-Induced Cardiotoxicity by Regulating the PTEN/Akt Pathway. BioMed research international 2020 (2020)
Ming-Xia Duan, Heng Zhou, Qing-Qing Wu, Chen Liu, Yang Xiao, Deng Wei, Qi-Zhu Tang
Andrographolide Protects against HG-Induced Inflammation, Apoptosis, Migration, and Impairment of Angiogenesis via PI3K/AKT-eNOS Signalling in HUVECs. Mediators of inflammation 2019 (2019)
Qing-Qing Wu, Deng Wei, Yang Xiao, Jiao-Jiao Chen, Chen Liu, Juan Wang, Yankai Guo, Mingxia Duan, Zhulan Cai, Saiyang Xie, Yuan Yuan, Qi-Zhu Tang
The 5-Lipoxygenase Inhibitor Zileuton Protects Pressure Overload-Induced Cardiac Remodeling via Activating PPARα. Oxidative medicine and cellular longevity 2019 (2019)
Hai-Han Liao, Nan Zhang, Yan-Yan Meng, Hong Feng, Jing-Jing Yang, Wen-Jin Li, Si Chen, Hai-Ming Wu, Deng Wei, Qi-Zhu Tang
Myricetin Alleviates Pathological Cardiac Hypertrophy via TRAF6/TAK1/MAPK and Nrf2 Signaling Pathway. Oxidative medicine and cellular longevity 2019 (2019)